Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Karolinska Development EPS Diluted (Quarterly): 0.0001 for March 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0001 |
| December 31, 2023 | -0.0009 |
| September 30, 2023 | 0.0037 |
| June 30, 2023 | 0.0086 |
| March 31, 2023 | -0.0096 |
| December 31, 2022 | 0.0047 |
| September 30, 2022 | -0.0162 |
| June 30, 2022 | -0.0082 |
| March 31, 2022 | -0.014 |
| December 31, 2021 | -0.0125 |
| September 30, 2021 | -0.0012 |
| June 30, 2021 | 0.1463 |
| March 31, 2021 | -0.0167 |
| December 31, 2020 | 0.0505 |
| September 30, 2020 | -0.097 |
| June 30, 2020 | 0.0009 |
| March 31, 2020 | -0.0663 |
| December 31, 2019 | 0.4151 |
| September 30, 2019 | -0.0212 |
| June 30, 2019 | 0.0113 |
| March 31, 2019 | -0.028 |
| December 31, 2018 | 0.0235 |
| September 30, 2018 | 0.0059 |
| June 30, 2018 | 0.0501 |
| March 31, 2018 | -0.0339 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0511 |
| September 30, 2017 | 0.3302 |
| June 30, 2017 | -0.0342 |
| March 31, 2017 | -0.0466 |
| December 31, 2016 | -0.0431 |
| September 30, 2016 | -0.0353 |
| June 30, 2016 | -0.1542 |
| March 31, 2016 | -0.1971 |
| December 31, 2015 | -0.2375 |
| September 30, 2015 | -0.0542 |
| June 30, 2015 | -1.296 |
| March 31, 2015 | -0.5026 |
| December 31, 2014 | -0.1097 |
| September 30, 2014 | -0.315 |
| June 30, 2014 | -0.5316 |
| March 31, 2014 | -0.0521 |
| December 31, 2013 | -0.2788 |
| September 30, 2013 | -0.2572 |
| June 30, 2013 | 0.10 |
| March 31, 2013 | 0.1872 |
| December 31, 2012 | 0.2131 |
| September 30, 2012 | -0.3244 |
| June 30, 2012 | -0.2336 |
| March 31, 2012 | -0.2218 |
| December 31, 2011 | -0.2875 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.097
Minimum
Sep 2020
0.4151
Maximum
Dec 2019
0.0189
Average
-0.001
Median
EPS Diluted (Quarterly) Benchmarks
| Abliva AB | -0.0019 |
| Calliditas Therapeutics AB | -0.064 |
| Oncopeptides AB | -0.0417 |
| Olink Holding AB | -0.13 |
| BioInvent International AB | -0.1138 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.0201M |
| Revenue (Quarterly) | 0.0454M |
| Total Expenses (Quarterly) | 0.8479M |
| Enterprise Value | 62.17M |
| Profit Margin (Quarterly) | 44.16% |
| Earnings Yield | 4.43% |
| Normalized Earnings Yield | -3.061 |